ESC Premium Access

Anthracycline-induced arterial toxicity: structural and inflammatory assessments in non-human primates and lymphoma patients using 18F-FDG positron emission tomography

Congress Presentation

About the speaker

Doctor Stephen Rankin

BHF Glasgow Cardiovascular Research Centre, Glasgow (United Kingdom of Great Britain & Northern Ireland)
0 follower

5 more presentations in this session

Prospective screening and proposed treatment algorithm for immune checkpoint inhibitor induced myositis in neoadjuvant-treated rectal cancer patients: data from the phase II CHINOREC trial

Speaker: Doctor R. Zirnbauer (Vienna, AT)

Thumbnail

Cardioprotective role of statins in breast cancer patients treated with anthracyclines and/or trastuzumab: a systematic review and meta-analysis

Speaker: Doctor S. Lingamsetty (Khammam, IN)

Thumbnail

Validation of the HFA-ICOS risk assessment tool with real-world data from a prospective cohort of breast cancer patients in treatment with anthracyclines and trastuzumab

Speaker: Doctor E. Guerra (Tlalpan, MX) Doctor N. Espinola-Zavaleta (Mexico City, MX)

Thumbnail

Comparison of two anthracycline regimens for treatment of breast cancer and the incidence of cardiac injury

Speaker: Doctor N. Osataphan (Chiang Mai, TH)

Thumbnail

Incidence, definitions and outcomes of anthracycline induced subclinical and clinical left ventricular dysfunction: a systematic review and meta-analysis

Speaker: Doctor N. Farooqui (Rochester, US)

Thumbnail

Access the full session

Cardiomyopathy in cancer patients: prevalence, risk assessment, imaging, and prevention

Speakers: Doctor S. Rankin, Doctor R. Zirnbauer, Doctor S. Lingamsetty, Doctor E. Guerra, Doctor N. Espinola-Zavaleta...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations